Connection
Tejas Patil to Pyrazoles
This is a "connection" page, showing publications Tejas Patil has written about Pyrazoles.
|
|
Connection Strength |
|
|
|
|
|
0.300 |
|
|
|
-
Tsui DCC, Kavanagh BD, Honce JM, Rossi C, Patil T, Camidge DR. Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib. Clin Lung Cancer. 2022 01; 23(1):e5-e8.
Score: 0.159
-
Patil T, Camidge DR. Untapped potential: recognising CNS opportunities in early oncology drug development. Lancet Oncol. 2019 12; 20(12):1620-1622.
Score: 0.141